NeuroBo Pharmaceuticals Inc (NRBO)
2.53
-0.14
(-5.24%)
USD |
NASDAQ |
Nov 04, 16:00
2.67
+0.14
(+5.53%)
After-Hours: 07:28
NeuroBo Pharmaceuticals Enterprise Value: -6.462M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | -6.462M |
| November 01, 2024 | -5.274M |
| October 31, 2024 | -6.123M |
| October 30, 2024 | -5.444M |
| October 29, 2024 | -3.662M |
| October 28, 2024 | -3.747M |
| October 25, 2024 | -4.341M |
| October 24, 2024 | -4.171M |
| October 23, 2024 | -3.916M |
| October 22, 2024 | -3.492M |
| October 21, 2024 | -3.152M |
| October 18, 2024 | -2.219M |
| October 17, 2024 | -1.116M |
| October 16, 2024 | -2.813M |
| October 15, 2024 | -6.462M |
| October 14, 2024 | -6.378M |
| October 11, 2024 | -6.208M |
| October 10, 2024 | -6.972M |
| October 09, 2024 | -5.274M |
| October 08, 2024 | -5.444M |
| October 07, 2024 | -5.020M |
| October 04, 2024 | -4.765M |
| October 03, 2024 | -5.444M |
| October 02, 2024 | -5.104M |
| October 01, 2024 | -3.068M |
| Date | Value |
|---|---|
| September 30, 2024 | -1.031M |
| September 27, 2024 | 0.2422M |
| September 26, 2024 | -0.0124M |
| September 25, 2024 | 0.2422M |
| September 24, 2024 | -0.7762M |
| September 23, 2024 | -0.8611M |
| September 20, 2024 | -0.8611M |
| September 19, 2024 | -0.267M |
| September 18, 2024 | 0.9211M |
| September 17, 2024 | 1.176M |
| September 16, 2024 | 1.261M |
| September 13, 2024 | 2.703M |
| September 12, 2024 | 3.043M |
| September 11, 2024 | 3.892M |
| September 10, 2024 | 4.995M |
| September 09, 2024 | 6.947M |
| September 06, 2024 | 1.770M |
| September 05, 2024 | 0.5587M |
| September 04, 2024 | 0.6665M |
| September 03, 2024 | 1.846M |
| August 30, 2024 | 3.382M |
| August 29, 2024 | 1.855M |
| August 28, 2024 | 1.600M |
| August 27, 2024 | 1.430M |
| August 26, 2024 | 1.006M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-20.46M
Minimum
Jun 23 2023
454.09M
Maximum
Feb 12 2020
40.98M
Average
5.558M
Median
Enterprise Value Benchmarks
| Cytokinetics Inc | 5.655B |
| Ocugen Inc | 260.88M |
| enVVeno Medical Corp | 11.42M |
| Scholar Rock Holding Corp | 2.074B |
| Mirum Pharmaceuticals Inc | 1.958B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.05M |
| Total Expenses (Quarterly) | 10.08M |
| EPS Diluted (Quarterly) | -1.85 |
| Earnings Yield | -194.1% |